Finix Ramadan 2026

Finix Ramadan 2026
Finix Ramadan 2026
Developer: Opsonin Pharma Ltd.
Category: Productivity
6.2K installs
Ratings not yet available
298 monthly active users
Revenue not available
Install Trends
Weekly +8.00
Trending
Monthly +77
Trending

Finix Ramadan 2026 Summary

Finix Ramadan 2026 is a mobile Android app in Productivity by Opsonin Pharma Ltd.. Released in May 2018 (7 years ago). It has about 6.2K+ installs Based on AppGoblin estimates, it reaches roughly 298 monthly active users . Store metadata: updated Mar 1, 2026.

Recent activity: 8.00 installs this week (77 over 4 weeks) showing exceptional growth View trends →

Store info: Last updated on Google Play on Mar 1, 2026 .


0★

Ratings: 0

5★
4★
3★
2★
1★

Screenshots

App screenshot
App screenshot
App screenshot
App screenshot

App Description

Ramadan Calendar developed by Opsonin Pharma Ltd.

Finix Ramadan Calendar & Hajj Guide is an app offered by Opsonin Pharma Ltd. This application is a Ramadan application that will keep you updated about the Sehr and Iftar timings but not limited to. This app has more feature that will help you with your daily prayer. Features of the app given below:

Prayer Time: District Wise Ramadan Calendar & Division Wise Prayer Time
Reminder: Iftar, Sehri and Prayer Time reminder
Dua: Ramadan Dua
Al-Quran: All surah of Al-Quran with meaning and available to download
Guide: Hajj Guideline
Calculator: Islamic Zakat Calculator
Qibla: Qibla Compass
Tasbih Counter

About Us

Opsonin Pharma Ltd. (OPL) develops, manufactures and markets generic medicines for human use. Our value-added products improve the quality of life of people In Bangladesh as well as abroad and help them enjoy longer, healthier, and more productive lives. OPL has been known for long as a provider of quality medicines at affordable prices. OPL is now manufacturing 281 brands with 670 SKUs as Pharmaceutical finished products. In the year of 1956, OPL started its journey.



For further information, visit us on

www.opsonin-pharma.com
www.facebook.com/OpsoninPharma